![Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets: Molecular Therapy - Methods & Clinical Development Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/6062b00f-e6e9-4767-addd-318572cb4644/fx1_lrg.jpg)
Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets: Molecular Therapy - Methods & Clinical Development
![Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice: Molecular Therapy - Methods & Clinical Development Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/asset/d776cddc-059f-44b3-bfd0-262a15445024/fx1.jpg)
Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice: Molecular Therapy - Methods & Clinical Development
![Vaccines | Free Full-Text | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations Vaccines | Free Full-Text | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations](https://www.mdpi.com/vaccines/vaccines-09-00221/article_deploy/html/images/vaccines-09-00221-g002.png)
Vaccines | Free Full-Text | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
![Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS](https://www.science.org/do/10.1126/science.abg2359/abs/vaccine_1280p_3.jpg)
Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS
![COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - ScienceDirect COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1939455121000119-gr1.jpg)
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - ScienceDirect
![Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS](https://www.pnas.org/cms/asset/2de643c2-7c12-4647-9f85-d316cb6f075b/keyimage.jpg)
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses | PNAS
![The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines | Nature Nanotechnology The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines | Nature Nanotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41565-021-01001-3/MediaObjects/41565_2021_1001_Fig1_HTML.png)
The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines | Nature Nanotechnology
![Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response](https://www.frontiersin.org/files/Articles/878943/fimmu-13-878943-HTML-r1/image_m/fimmu-13-878943-g001.jpg)
Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
![Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response](https://www.frontiersin.org/files/Articles/878943/fimmu-13-878943-HTML-r1/image_m/fimmu-13-878943-g004.jpg)
Frontiers | Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
![Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives - Sampath - 2021 - Allergy - Wiley Online Library Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives - Sampath - 2021 - Allergy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/38fc4943-2b97-45eb-b0d8-2c74bf1d7ff2/all14840-fig-0002-m.jpg)
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives - Sampath - 2021 - Allergy - Wiley Online Library
![A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice - ScienceDirect A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001620301994-fx1.jpg)